Evaluation and Implementation Preparation of a Proactive Palliative Care Model (ENABLE-SG)

ConditionNeoplasms
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-120
SponsorNational Cancer Centre, Singapore

About this trial

The current interdisciplinary specialist palliative care model focuses on supporting patients with advanced cancer who have complex problems in the last weeks of life. Consequently, palliative care is often provided late and in response to uncontrolled symptoms during crises. Palliative care models should shift from this reactionary illness-stress paradigm to a proactive health-wellness approach that is integrated early in the patient's disease trajectory.

A proactive early palliative care telehealth model, ENABLE (Educate, Nurture, Advise, Before Life Ends), was developed in the U.S. to coach patients with advanced cancers and their family caregivers on how to cope effectively with serious illness. By empowering individuals early before acute distress and symptoms occur, patients and families can better mitigate and avoid crises. Building on positive health outcomes demonstrated by the ENABLE model in the U.S., the study team has successfully pilot-tested a culturally adapted ENABLE-SG model in Singapore. This study seeks to test the effectiveness of this ENABLE-SG model among patients with recently diagnosed advanced cancer and their caregivers while simultaneously collecting data on real-world implementation.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Adult aged 21 and above

Within 60 days of being informed of an advanced cancer diagnosis, defined as metastatic or recurrent/ progressive Stage III/IV solid tumour

Able to speak English or Chinese

Able to provide informed consent

Disqualifiers

Medical record documentation of an active severe mental illness, dementia, active suicidal ideation, uncorrected hearing loss

Unable to complete patient-reported outcome measures

Has been reviewed by palliative care services in the current model of palliative care.

Self-reported severe mental illness, dementia, active suicidal ideation, uncorrected hearing loss

Trial design

Design model

Parallel

Treatments tested in this trial

  • ENABLE-SG model

    Behavioral

    Patients and caregivers will receive individual structured psycho-educational sessions with a health coach. These sessions will be primarily delivered over the phone. Patient and caregiver dyads will have different health coaches. Patients will have six sessions on the topics of maintaining positivity, self-care, coping with stress, managing symptoms, exploring what matters most, and life review. Caregivers will have four sessions on the topics of maintaining positivity, self-care, coping with stress, and managing symptoms. All sessions will begin with screening for distress using the Distress Thermometer and Problem List culturally adapted from the National Comprehensive Cancer Network. From screening results, the health coach can flexibly change the order of the topics to address specific problems. It will take approximately three months to complete all sessions.

  • Wait-list control

    Other intervention

    * 6-month wait-list control. Participants will receive the ENABLE-SG model six months after baseline (six sessions for patients and four sessions for caregivers) at an approximately weekly interval. * Interventions: ENABLE-SG model

Treatment groups

715 Participants
are divided into 2 treatment groups
Group A: ENABLE-SG (immediate group)Experimental treatment 1 intervention
Group B: Wait-list controlOther 1 intervention

Trial outcomes

Primary outcomes

1

Health-related quality of life of patients with advanced cancer

Quality of life score measured using the Functional Assessment of Chronic Illness Therapy - Palliative (FACIT-Pal), a 46-item measure with a quality of life scale (4 domains: physical, emotional, social, and functional well-being) and a palliative care subscale. It has demonstrated internal consistency, reliability and validity for persons with advanced cancer. Scores range from 0 to 184, with higher scores indicating better quality of life.

Time frame
6th month.

Secondary outcomes

1

Health-related quality of life of caregivers

Quality of life score measured using the Singapore Caregiver Quality of Life Scale (SCQOLS), a 15-item quality of life measure covering 5 domains: physical well-being, mental well-being, experience \& meaning, impact on daily living, and financial well-being. The domain scores will be scaled to range from 0 to 100, with a higher score indicating better quality of life.

Time frame
6th month.
2

Longitudinal changes in health-related quality of life of patients with advanced cancer across assessment timepoints

Longitudinal changes in quality of life score measured using the Functional Assessment of Chronic Illness Therapy - Palliative (FACIT-Pal), across assessment timepoints. FACIT-Pal is a 46-item measure with a quality of life scale (4 domains: physical, emotional, social, and functional well-being) and a palliative care subscale. It has demonstrated internal consistency, reliability and validity for persons with advanced cancer. Scores range from 0 to 184, with higher scores indicating better quality of life.

Time frame
Baseline, 3rd month, 6th month, 9th month, 12th month.
3

Longitudinal changes in health-related quality of life of caregivers across assessment timepoints

Longitudinal changes in quality of life score measured using the Singapore Caregiver Quality of Life Scale (SCQOLS), across assessment timepoints. SCQOLS is a 15-item quality of life measure covering 5 domains: physical well-being, mental well-being, experience \& meaning, impact on daily living, and financial well-being. The domain scores will be scaled to range from 0 to 100, with a higher score indicating better quality of life.

Time frame
Baseline, 3rd month, 6th month, 9th month, 12th month.
4

Mood of patients with advanced cancer and their caregivers

Mood measured using the Center for Epidemiological Studies-Depression (CES-D), a 20-item measure of symptoms clustered in 4 domains: depressed affect, somatic complaints, positive affect, and interpersonal activity. Scores will be scored to a total score ranging from 0 to 60, with higher scores indicating greater frequency of depressive experiences.

Time frame
Baseline, 3rd month, 6th month, 9th month, 12th month.

Other outcomes

1

Acceptability and adoption of ENABLE-SG among patients with advanced cancer and their caregivers.

An investigator-designed structured feedback survey on acceptability, relevance, comfort level, overall satisfaction, and intention to recommend ENABLE-SG to others in similar situations. All items are rated on a 5-point Likert scale.

Time frame
At the end of study participation, up to the 12th month.
2

Appropriateness and feasibility of ENABLE-SG among patients with advanced cancer, their caregivers, and healthcare providers

Semi-structured interviews conducted using an interview guide developed based on the Consolidated Framework for Implementation Research (CFIR).

Time frame
≥6 months after baseline.
3

Fidelity of the delivery of ENABLE-SG

Fidelity to the health coaching protocol (intervention) will be assessed by a narrative synthesis of any modifications or deviations from the protocol. These modifications/ deviations will be extracted from self-reporting checklists, field notes, recordings of the actual health coaching sessions, and discussions of the completed health coaching sessions.

Time frame
Through study completion, anticipated up to 3 years.
4

Implementation cost

Process maps and project records detailing key intervention activities to elucidate cost of involved personnel and resources through a time-tracking system and an activity-based costing approach.

Time frame
Through study completion, anticipated up to 3 years.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.